Jay Dinerman, MD
Clinical Cardiac Electrophysiology · Huntsville, ALNPI 1740250018
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 60.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $8,698 and has fallen 94.6% since, to $467 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AL, where the typical reported total is $17,214.
Across 144 payments — averaging $92.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Abbott$4K
- Medtronic$621
- Biosense Webster, Inc.$258
- Philips North America LLC$124
- Pfizer$90
- plus $186 from 6 others
Across 140 payments — averaging $6420.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$588K
- Abbott$219K
- Medtronic$91K
What the payments were for
- Consulting fees$2,65620%
- Speaking & faculty fees$5,50041%
- Travel & lodging$7796%
- Food & beverage$4,35333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 62 | $8,051 |
| Abbott | 38 | $3,957 |
| Medtronic(2 entities) | 22 | $621 |
| Biosense Webster, Inc. | 5 | $258 |
| Philips North America LLC | 1 | $124 |
| Pfizer | 5 | $90 |
| Gilead | 4 | $62 |
| Novo Nordisk | 2 | $41 |
| Johnson & Johnson | 2 | $26 |
| Novartis | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Elutia, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$5,607
- Fortify Assura$1,094
- Agilis NxT EP Introducer$938
- RESONATE$920
- TENDRIL$625
- Accent Pacemaker$266
- Carto 3$180
- ASSURITY$165
- WATCHMAN Access System$152
- (9525) EP Undivided$124
- Attain$119
- RESONATE EL ICD VR$115
- ENSITE PRECISION$112
How this compares
$13,288 in reported general payments places this provider in the 35th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 163 | $169,542 |
| EntrestoSacubitril/Valsartan | 32 | $30,115 |
| XareltoRivaroxaban | 25 | $21,134 |
| Flecainide Acetate | 131 | $5,925 |
| Propafenone Hcl | 35 | $3,588 |
| PradaxaDabigatran Etexilate Mesylate | 12 | $2,128 |
| SotalolSotalol Hcl | 47 | $1,219 |
| Metoprolol Succinate | 58 | $1,201 |
| Amiodarone Hcl | 53 | $897 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 29 | $595 |
| Digoxin | 25 | $570 |
| Carvedilol | 59 | $243 |
| Atorvastatin Calcium | 21 | $212 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 67 | $158 |
| Nifedipine ErNifedipine | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $90 | $169,542163 claims |
| NovartisEntresto | $22 | $30,11532 claims |
| Johnson & JohnsonXarelto | $26 | $21,13425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Huntsville
- Jeffery AllisonHuntsville$18K
- John JenningsHuntsville$15K
- Michael KaufmannHuntsville$14K
- Paul TabereauxHuntsville$9K
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.